An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation

Increasing evidence suggests that signaling through the prolactin/prolactin receptor axis is important for stimulation the growth of many cancers including glioblastoma multiforme, breast and ovarian carcinoma. Efficient inhibitors of signaling have previously been developed but their applicability...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shengze, Alkharusi, Amira, Norstedt, Gunnar, Gräslund, Torbjörn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504076/
https://www.ncbi.nlm.nih.gov/pubmed/31063493
http://dx.doi.org/10.1371/journal.pone.0215831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504076/
https://www.ncbi.nlm.nih.gov/pubmed/31063493
http://dx.doi.org/10.1371/journal.pone.0215831

Ejemplares similares